Innovative Vector Control Consortium

What Innovative Vector Control Consortium does

Innovative Vector Control Consortium (IVCC) is a UK-registered charity and the only Product Development Partnership (PDP) dedicated to vector control, founded in 2005 with an initial $50 million grant from the Bill & Melinda Gates Foundation. Headquartered at the Liverpool School of Tropical Medicine, the organization develops and accelerates the market introduction of innovative vector control tools that combat insect-borne diseases, primarily malaria. Its technology portfolio spans four pillars: insecticide-treated nets (ITNs) including dual active ingredient products such as Interceptor G2 and Royal Guard; indoor residual spraying (IRS) products such as Fludora Fusion, SumiShield 50WG, and Actellic 300CS; spatial emanators for indoor protection; and outdoor biting control tools such as Attractive Targeted Sugar Baits (ATSB).

IVCC does not sell products directly. Instead, it operates as a coordination and de-risking platform that works with agricultural chemical industry partners (BASF, Sumitomo Chemical, Syngenta, Envu), procurement mechanisms (Global Fund, Unitaid), regulatory bodies (WHO prequalification), national malaria control programmes, and a network of eight GLP-certified African research facilities. The organization's value proposition centers on bridging industry, academia, and public health to translate novel chemistry and formulations into WHO-prequalified products deployed at scale. Its 2024-2028 strategy focuses on insecticide resistance management, outdoor transmission control, and adoption of new product categories including spatial emanators.

Revenue flows from a concentrated base of institutional donors (Gates Foundation, UK Aid, Swiss SDC, Australian DFAT, Unitaid) rather than commercial sales. The organization has delivered measurable public health outcomes, including the New Nets Project's deployment of 56 million dual insecticide nets across 17 sub-Saharan African countries and an estimated 13 million malaria cases averted. With 11-50 staff and a network exceeding 20 global partnerships, IVCC functions as a small, specialized, impact-oriented platform whose scale of public health outcomes substantially exceeds its organizational footprint.

Name

Innovative Vector Control Consortium

Legal name

Innovative Vector Control Consortium

Website

https://ivcc.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Innovative Vector Control Consortium (IVCC) is a UK-based not-for-profit Product Development Partnership that develops and accelerates WHO-prequalified insecticides, insecticide-treated nets, and spatial emanators for malaria and vector-borne disease control in endemic countries through industry, academic, and donor partnerships.

Ownership category

akta.pro rank

Product category

Public Health Vector Control (Malaria)

NAICS

Scientific Research and Development Services (5417)

akta.pro primary industry

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)

Keywords

• Vector control innovation
• Malaria prevention tools
• Insecticide-treated nets
• Public health partnerships
• Insecticide resistance management

Headquarters

HQ city

Liverpool

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Grant Funding: IVCC is a not-for-profit charity funded through grants from foundations and government donors. Funding partners include the Bill & Melinda Gates Foundation (initial $50M grant in 2005), UK Aid, Swiss Agency for Development and Cooperation, and Australian Department of Foreign Affairs and Trade. These grants support product development activities from discovery through market introduction.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

IVCC is a Product Development Partnership that develops and accelerates vector control tools to prevent the transmission of insect-borne diseases, principally malaria. Its core work spans discovery and screening of novel and repurposed insecticides, development of finished products (insecticide-treated nets, indoor residual spray formulations, spatial emanators, attractive targeted sugar baits), and supporting their introduction into malaria-endemic country programmes through WHO prequalification and partnerships with industry and global health procurers.

Product overview

IVCC is the only Product Development Partnership (PDP) dedicated to vector control, operating as a platform of interconnected vector control products and programs. The core product portfolio spans four technology pillars: Insecticide Treated Nets (ITNs) including Interceptor G2 and Royal Guard; Indoor Residual Spraying (IRS) products including Fludora Fusion, SumiShield 50WG, Actellic 300CS, Vectron T500, and K-Othrine Polyzone; Spatial Emanators for indoor protection; and Outdoor Biting Control tools including Attractive Targeted Sugar Baits (ATSB). These are supported by strategic programs such as the New Nets Project, Indo-Pacific Initiative (IPI), NgenIRS, and NATNAT Programme. IVCC works with industry partners to develop and bring these vector control tools from discovery through to market deployment, addressing insecticide resistance and expanding the range of available malaria prevention solutions.

Differentiator

Problem solved

Functional benefit

Products and services

• Interceptor G2 WHO-prequalified insecticide-treated net combining two insecticides with different modes of action to overcome pyrethroid resistance, deployed in malaria-endemic countries.
• Royal Guard Dual active ingredient insecticide-treated net supported by IVCC for market entry, combining insecticides to combat insecticide resistance.
• Fludora Fusion Indoor residual spray formulation developed with partner BASF, providing long-lasting protection against malaria vectors through a combination of two actives.
• SumiShield 50WG Indoor residual spray product with novel mode of action for IRS programmes targeting pyrethroid-resistant mosquitoes.
• Actellic 300CS Indoor residual spray formulation introduced with a novel mode of action to support IRS programmes in malaria-endemic settings.
• Vectron T500 Indoor residual spray product introduced as part of IVCC's IRS portfolio to support resistance management in malaria vector control.
• K-Othrine Polyzone Indoor residual spray formulation for malaria vector control developed through IVCC industry partnerships.
• Attractive Targeted Sugar Baits (ATSB) Outdoor biting control tool designed to attract and kill mosquitoes seeking sugar sources, addressing outdoor malaria transmission where ITNs and IRS are less effective.
• Spatial Emanators Devices that release insecticide vapors to kill, disarm and repel mosquito vectors indoors, serving as alternatives to volatile pyrethroids in regions with resistance concerns (e.g., SC Johnson's Guardian and Mosquito Shield).
• New Nets Project Multi-country programme that developed and introduced dual-insecticide-treated nets across 17 countries in sub-Saharan Africa with Unitaid and Global Fund, averting an estimated 13 million malaria cases.
• NgenIRS Programme supporting indoor residual spraying operations and market access for IRS products in malaria-endemic countries, including Africa regional coordination.
• Indo-Pacific Initiative (IPI) Regional initiative to develop a vector control toolbox for the Indo-Pacific region, including evaluation of spatial emanators, outdoor control tools, and Aedes/dengue control with partners in Malaysia, Mexico and US.
• NATNAT Programme Programme building capacity in Papua New Guinea for rapid evaluation and adoption of new vector control tools, including spatial emanators and other novel interventions.
• ResistanceSIM Modelling tool for simulating and managing insecticide resistance scenarios, supporting decision-making on resistance management strategy by IVCC and its partners.

Quantifiable outcome

• Vector control has prevented over 1.22 billion malaria cases in Africa since 2000
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

22 partnerships are on record, tiered major and core.

• Tulane UniversitymajorStrategic or Co-development Partner · 1 January 2026Collaboration with Celia Scott Weatherhead School of Public Health and Tropical Medicine to support evidence generation for spatial emanator deployment, including epidemiological effectiveness and cost-effectiveness studies.
• SC JohnsoncoreStrategic or Co-development Partner · 1 January 2025Manufacturer of WHO-prequalified spatial emanator products (Guardian and Mosquito Shield). IVCC supports evidence generation and deployment of these products in malaria-endemic countries.
• BASFcoreStrategic or Co-development PartnerIndustry partner collaborating on development of dual-insecticide treated nets. BASF is a key chemical company partner in the New Nets Project for bringing new vector control products to market.
• Global FundcoreStrategic or Co-development PartnerKey procurement and funding partner for malaria control commodities. The Global Fund procures and distributes vector control products including dual insecticide nets developed through IVCC partnerships.
• Liverpool School of Tropical MedicinecoreStrategic or Co-development PartnerHost institution for IVCC, providing organizational infrastructure and research capabilities. IVCC is part of the LSTM Group and is registered as a charity at this location.
• World Health Organization (WHO)coreStrategic or Co-development PartnerIVCC works with WHO on vector control guidelines, prequalification processes, and policy development. WHO provides technical guidance and regulatory pathways for vector control products.
• PNG Institute of Medical ResearchmajorStrategic or Co-development PartnerPartner in Papua New Guinea for testing novel vector control tools through the NATNAT project. IVCC supports establishment of national infrastructure for evaluating spatial emanators and other tools.
• Innovation to Impact (i2i)majorStrategic or Co-development PartnerPartner organization supporting GLP certification and quality management systems for vector control research facilities in Africa. Joint initiative since 2010 for laboratory and field trial standardization.
• PAMVERC-KCMUCo (Tanzania)majorStrategic or Co-development PartnerGLP-certified research facility in Tanzania for vector control product evaluation. One of 5 African research facilities granted GLP certification by SANAS.
• Ifakara Health Institute (Tanzania)majorStrategic or Co-development PartnerGLP-certified research facility in Tanzania. IVCC supports facility development and conducts data analysis workshops with IHI.
• CREC/LSHTM (Benin)majorStrategic or Co-development PartnerGLP-certified collaborative research facility in Benin for IRS and ITN product evaluation. Part of IVCC's network of African trial facilities.
• Centre Suisse de Recherches Scientifiques (CSRS, Côte d'Ivoire)majorStrategic or Co-development PartnerGLP-certified research facility in Côte d'Ivoire supported by IVCC for vector control product evaluation.
• Institut Pierre Richet (IPR, Côte d'Ivoire)majorStrategic or Co-development PartnerGLP-certified facility (VCPEC) in Bouaké, Côte d'Ivoire for mosquito vector control research.
• Sumitomo ChemicalcoreStrategic or Co-development PartnerIndustry partner for vector control product development including IRS products. Part of IVCC's network of agricultural chemical companies developing public health insecticides.
• MitsuicoreStrategic or Co-development PartnerJapanese trading company partner in IVCC's industry network for vector control product development and market access.
• SyngentacoreStrategic or Co-development PartnerAgricultural science company partner for vector control product development, providing expertise in insecticide chemistry and formulation.
• EnvucoreStrategic or Co-development PartnerEnvironmental science company (formerly Bayer Environmental Science) specializing in vector control products including those for malaria prevention.
• Malaria Atlas Project (MAP)majorStrategic or Co-development PartnerResearch collaboration providing geospatial modeling and analysis of malaria impact. MAP and IVCC co-authored analysis showing vector control prevented 1.22 billion malaria cases since 2000.
• Universiti Sains Malaysia (Vector Control Research Unit)majorStrategic or Co-development PartnerResearch partner in Malaysia for Aedes control tool evaluation as part of IVCC's Indo-Pacific Initiative.
• Institute of Medical Research (Malaysia)majorStrategic or Co-development PartnerGovernment research institute partner in Malaysia for vector control research and dengue control tool evaluation.
• Universidad Autónoma de YucatánmajorStrategic or Co-development PartnerMexican university partner contributing expertise in evaluating and implementing novel vector control tools for dengue control.
• Emory UniversitymajorStrategic or Co-development PartnerUS university partner providing expertise in vector control evaluation and implementation for the Indo-Pacific Initiative.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• FIND (Foundation for Innovative New Diagnostics): FIND is a Geneva-based PDP driving development and delivery of diagnostic tests for poverty-related diseases, including malaria. Like IVCC, it bridges industry, academia, and global health actors; depends on Gates Foundation and government funding; and works through WHO prequalification and global procurement channels.
• Medicines for Malaria Venture (MMV): MMV is the most direct structural peer to IVCC — a Product Development Partnership focused on malaria, but for therapeutics rather than vector control. Both operate PDP models funded by Gates Foundation and government donors to address the same disease through different intervention layers, and both rely on WHO prequalification pathways and partnerships with downstream procurement (Global Fund, PMI).
• Gavi, the Vaccine Alliance: Gavi is the most prominent health-focused PDP globally, accelerating vaccine access in low-income countries. While focused on a different intervention category (vaccines vs. vector control), Gavi shares IVCC's donor-driven model, country-engagement playbook, and dependence on procurement funders like Gavi/PMI/Global Fund — making it a strong operational peer for the PDP model itself.
• TB Alliance: TB Alliance is a PDP developing new tuberculosis treatments, founded in 2000. It operates a comparable not-for-profit, multi-donor, partnership-based model and shares with IVCC the focus on infectious diseases of poverty, WHO guideline-driven demand, and reliance on global procurement mechanisms.
• Drugs for Neglected Diseases Initiative (DNDi): DNDi is a Geneva-based PDP addressing neglected tropical diseases, including malaria and leishmaniasis. It shares IVCC's funding model (multi-donor grants including Gates Foundation and government aid), partnership-led drug discovery approach, and focus on diseases disproportionately affecting low-income endemic countries.

Others

• Roll Back Malaria Partnership (RBM): RBM is the global coordination platform for malaria control partners, including IVCC. It is not a direct peer but an ecosystem-level coordinator whose policy advocacy and country support amplify IVCC's products and influence national malaria control program adoption.
• The Global Fund to Fight AIDS, Tuberculosis and Malaria: The Global Fund is the largest multilateral procurer of malaria commodities and a core IVCC partner that funds and procures dual-AI nets and IRS products developed through IVCC partnerships. It is a funder/ecosystem partner rather than a competitor, but its procurement decisions shape demand for IVCC's product portfolio.
• PMI VectorLink Project (Abt Associates): Implemented by Abt Associates, PMI VectorLink is the operational vehicle for the U.S. President's Malaria Initiative's indoor residual spraying programs — the same IRS product category in which IVCC has been central (NgenIRS, New Nets Project). Several IVCC team members (e.g., Dr. Gnanguenon) previously led PMI VectorLink country implementation, making it a closely linked ecosystem partner rather than a competitor.

Broad incumbents

• PATH: PATH is a large global health nonprofit with a broad portfolio spanning vaccines, diagnostics, maternal health, and malaria — including malaria vector control work. It is a broader incumbent in the same global-health-not-for-profit space, with overlapping funder base (Gates Foundation, USAID) and overlapping programmatic reach in malaria-endemic countries.

Emerging players

• Pan-African Mosquito Control Association (PAMCA): PAMCA is a regional professional association focused on coordinating and strengthening mosquito control across Africa. It overlaps with IVCC's vector-control focus and is explicitly a partner (Dr. Amelie Wamba previously coordinated PAMCA's Gene Drive network). It is a niche, region-specific player compared to IVCC's global PDP role.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/invectorcontrol
• LinkedInlinkedin.com/company/ivcc-innovative-vector-control-

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innovative Vector Control Consortium